$502 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 50 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BWXT | BWX TECHNOLOGIES INC | $19,514,880 | +15.3% | 336,000 | 0.0% | 3.89% | +79.5% | |
| APG | API GROUP CORP | $17,859,756 | +41.7% | 949,482 | 0.0% | 3.56% | +120.6% | |
| CARA | CARA THERAPEUTICS INC | $14,316,420 | +14.7% | 1,333,000 | 0.0% | 2.85% | +78.6% | |
| WSC | WILLSCOT MOBIL MINI HLDNG CO | $13,551,000 | +12.0% | 300,000 | 0.0% | 2.70% | +74.3% | |
| XAIR | BEYOND AIR INC | $5,166,274 | -12.8% | 796,036 | 0.0% | 1.03% | +35.8% | |
| SLGL | SOL GEL TECHNOLOGIES | $3,797,485 | -9.2% | 832,800 | 0.0% | 0.76% | +41.3% | |
| MSAC | MEDICUS SCIENCES ACQUISITION | $3,021,000 | +1.7% | 300,000 | 0.0% | 0.60% | +58.4% | |
| GEG | GREAT ELM GROUP INC | $2,785,679 | +1.0% | 1,379,049 | 0.0% | 0.56% | +57.2% | |
| SCYX | SCYNEXIS INC | $2,023,395 | -35.0% | 1,297,048 | 0.0% | 0.40% | +1.3% | |
| OSTK | OVERSTOCK COM INC DEL | $1,936,000 | -20.5% | 100,000 | 0.0% | 0.38% | +23.8% | |
| CRIS | CURIS INC | $1,388,433 | -21.4% | 2,524,424 | 0.0% | 0.28% | +22.1% | |
| ENVVENO MEDICAL CORPORATION | $1,117,818 | -18.8% | 219,180 | 0.0% | 0.22% | +26.7% | ||
| VINC | VINCERX PHARMA INC | $392,700 | -26.0% | 385,000 | 0.0% | 0.08% | +14.7% | |
| JASPER THERAPEUTICS INC | $260,766 | -38.8% | 540,000 | 0.0% | 0.05% | -3.7% | ||
| MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $3,117 | +211.7% | 33,332 | 0.0% | 0.00% | – | |
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $3,540 | +77.0% | 66,665 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
| SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
| ISHARES TR | 27 | Q3 2023 | 13.2% |
| HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
| SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
| META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
| LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
| NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
| AMAZON COM INC | 18 | Q3 2022 | 7.6% |
| SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
| GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
| Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
| Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
| Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
| AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
| FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
| Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
| Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-04-15 |
| 13F-HR/A | 2024-03-18 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2023-11-29 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.